Last reviewed · How we verify
NCT02693574
Comparison Efficacy of 14-day Triple Therapy: Clarithromycin vs. Levofloxacin on Eradication of H. Pylori
Phase 4 trial testing Clarithromycin in Helicobacter Pylori Gastrointestinal Tract Infection in 74 participants. Status unknown.
28 January 2017
Quick facts
| Lead sponsor | Damascus Hospital |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 74 |
| Start date | 1 December 2015 |
| Primary completion | 28 January 2017 |
| Estimated completion | 31 May 2017 |
| Sites | 1 location across Syria |
Drugs / interventions tested
- Clarithromycin (clarithromycin) — full drug profile →
- Levofloxacin (Levofloxacin) — full drug profile →
Conditions studied
- Helicobacter Pylori Gastrointestinal Tract Infection — all drugs for Helicobacter Pylori Gastrointestinal Tract Infection →
Sponsor
Damascus Hospital
Who can join
Adults 18 to 75, any sex, with Helicobacter Pylori Gastrointestinal Tract Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Comparison Efficacy of 14-day Triple Therapy between Clarithromycin and levofloxacin on the Eradication of Helicobacter Pylori in Syrian population
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT02693574
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Clarithromycin
Trials testing the same drug.
- NCT07040787 — Investigation of Drug-drug Interaction of HRS-5965 With Clopidogrel and Clarithromycin in Healthy Subjects · Phase 1 · completed
- NCT07086937 — Efficacy of Nitazoxanide Based Therapy vs Standard Triple Therapy in H-pylori in Children · NA · completed
- NCT06514274 — Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Era · Phase 4 · completed
- NCT06551623 — Drug-Drug Interactions Between TNP-2198 and Midazolam, Clarithromycin · Phase 1 · completed
- NCT06576882 — 7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication · Phase 3 · completed
Other recruiting trials for Helicobacter Pylori Gastrointestinal Tract Infection
Currently open trials in the same condition.
- NCT07293910 — Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Py · Phase 2 · recruiting
Other Damascus Hospital trials
Trials by the same sponsor.
- NCT06065267 — Levofloxacin Concomitant Versus Levofloxacin Sequential · Phase 4 · not yet recruiting
- NCT04626193 — LOAD VS Levofloxacine Concomitant · Phase 4 · unknown
- NCT04348786 — Comparing Efficacy of 14-day Therapy Doxycycline With Bismuth Subsalicylate Versus Levofloxacin With Tinadizole on Treat · Phase 4 · completed
- NCT03021590 — Comparison Efficacy of 14-day Concomitant Therapy:Clarithromycin vs.Levofloxacin in Eradication of H.Pylori · Phase 4 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02693574 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Damascus Hospital
- Last refreshed: 21 March 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02693574.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing